Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost

Advances in Therapy

Volumn 19, Issue 6, 2002, Pages 275-281

  Williams, Robert D ^a  

^a Taustine Eye Center   (United States)

Author keywords

Bimatoprost; Glaucoma; Latanoprost; Nonresponders; Ocular hypertension

Indexed keywords

BIMATOPROST; LATANOPROST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PIGMENT DISORDER; TREATMENT OUTCOME;

EID: 0036880790     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02853173     Document Type: Article

References (9)

1. Brubaker RF. Mechanism of action of bimatoprost (Lumigan™). Surv Ophthalmol. 2001;45(suppl 4):S347-S351.
2. Sherwood M, Brandt J. Six-month comparison of bimatoprost once daily and twice daily with timolol twice daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(suppl 4):S361-S368.
3. DuBiner H, Cooke D, Dirks M, et al. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol. 2001;45(suppl 4):S353-S360.
4. Gandolfi S, Simmons ST, Sturm R, et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001;18:110-121.
5. Noecker RJ, Dirks MS, Choplin NT, et al. A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol. 2003;135(1):55-63.
6. Toris CB, Camras CB, Yablonski ME. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100:1297-1304.
7. Scherer WJ. A retrospective review of non-responders to latanoprost. J Ocul Pharmacol Ther. 2002;18:287-291.
8. Gandolfi S, Cimino L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are non-responders to latanoprost. Ophthalmology. 2003 (in press).
9. Chen MJ, Lin S, Stamper RL. Efficacy and safety of bimatoprost as additive and replacement therapy in patients uncontrolled with latanoprost: early results. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology; May 2002; Ft. Lauderdale, Fla.